Author

K. Martinez-Mayorga

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Assay:protein structure· 1

Frequent Co-Authors

A. Madariaga-Mazon· 2 shared A. Hernandez-Cano· 1 shared E. Correa-Padilla· 1 shared F. Esquivel-Guadarrama· 1 shared G. Cuevas· 1 shared J. G. Rosas-Jimenez· 1 shared M. A. Garcia-Revilla· 1 shared Y. Acevedo-Betancur· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

A. Madariaga-Mazon

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Modifications in the piperazine ring of nucleozin affects anti-influenza activity

E. Correa-Padilla, A. Hernandez-Cano, G. Cuevas, Y. Acevedo-Betancur, F. Esquivel-Guadarrama, A. Madariaga-Mazon, K. Martinez-Mayorga

The paper evaluates nucleozin analogs with modified piperazine rings, finding that increased conformational flexibility reduces anti-influenza activity and supports a QSAR model for predicting activity.

bioRxiv · Oct 20, 2022Pharmacology & Toxicology

A validated and interpretable predictive model of cruzain inhibitors

J. G. Rosas-Jimenez, M. A. Garcia-Revilla, A. Madariaga-Mazon, K. Martinez-Mayorga

This paper develops a validated QSAR model to predict cruzain inhibitor activity, showing high internal and external predictability.

bioRxiv · Jun 2, 2020 · PreprintBiophysics